Session Type
Meeting
Search Results for covid
Abstract Number: N10
SHM Converge 2022
Background: Atrial fibrillation (AF) is condition associated with increased risk of death in multiple populations (1). The association between AF and COVID-19 infection has started to be explored, but largely in specific geographic locations and/or within the context of the hospitalization (2). By understanding the relationship between COVID-19 and AF, providers may be better supported […]
Abstract Number: O19
SHM Converge 2022
Background: Evidence-Based and Informed Clinical Practice is identified by the ACGME as a core clinical milestone (PBLI1). The Evidence Based Medicine (EBM) curriculum in the University of Wisconsin (UW) Internal Medicine Residency Program previously focused on didactics, journal clubs, and independent study. The COVID-19 pandemic interrupted these traditional EBM teaching methods, prompting us to re-evaluate […]
Abstract Number: O28
SHM Converge 2022
Case Presentation: A 52-year-old unvaccinated male with past medical history of asthma and uncontrolled obstructive sleep apnea presented to the ED ten days after receiving a diagnosis of COVID-19 with worsening dyspnea. He endorsed a cough, fever, chills, and non-bloody diarrhea, and denied chest pain, leg edema, and anosmia. His initial vitals were remarkable for an oxygen saturation of 65%. A CBC demonstrated leukopenia […]
Abstract Number: O32
SHM Converge 2022
Case Presentation: A 73-year-old male with a history of heart failure with preserved ejection fraction presented with one month of dizziness, weakness, dyspnea on exertion, and a 25-pound weight loss due to loss of appetite. On the day of admission, he had three brief episodes of syncope upon standing. His initial blood pressure was 64mmHg/40mmHg, […]
Oral Presentations
Abstract Number: OP1
SHM Converge 2022
Background: Hospitalizations to treat SARS-CoV-2 infected patients have strained health systems worldwide. Monitored outpatient management of select low-risk COVID-19 patients with isolated exertional hypoxia could help preserve hospital resources and reduce costs while aiming to maintain a high standard of care. In this retrospective cohort analysis, we aimed to evaluate the safety and effectiveness of […]
Oral Presentations
Abstract Number: OP3
SHM Converge 2022
Background: Early risk stratification scores utilizing data available at the bedside have been used regularly to identify patients at greatest risk of poor outcomes from rapidly evolving conditions like sepsis. Little is known about how point-of-care scores developed for sepsis perform at predicting outcomes in large, heterogeneous cohorts of patients with COVID-19. Our objective was […]
Abstract Number: P10
SHM Converge 2022
Background: Cancer patients are at risk of higher readmission rates after hospitalization, which has been associated with increased comorbidity and mortality. Development of acute kidney injury (AKI) is associated with worse clinical outcomes. In the setting of the COVID-19 pandemic, we aim to look at the 30-day readmission rate in our institution’s cancer patients with […]
Abstract Number: P32
SHM Converge 2022
Case Presentation: We present a case of rapidly progressive Hypereosinophilic Syndrome (HES), a possible late complication of Sars-CoV-2 (COVID-19). A previously healthy 48-yr old male recovered from COVID-19 approximately 30 days before symptom onset. He had fevers, chills, diffuse abdominal pain with nausea, vomiting, and diarrhea with diffuse erythematous pruritic rash and Raynaud’s phenomenon (Image […]
Abstract Number: P39
SHM Converge 2022
Case Presentation: A 28-year-old male patient presented to the hospital with central, non-radiating, moderate-intensity chest pain that started four days after his second dose of Pfizer-BioNTech COVID-19 vaccine. The patient had neither any prior history of SARS-COV2 infection nor known exposure to a symptomatic patient. He denied any fever, chills, diaphoresis, upper or lower respiratory […]
Plenary Presentations
Abstract Number: PL2
SHM Converge 2022
Background: Patients hospitalized with COVID-19 can clinically deteriorate in the second week of illness after a period of initial stability. Thus, an important clinical question is determining when it is safe to discharge these patients from the hospital without overwhelming hospitals’ capacities. Unfortunately, discharge criteria for COVID-19 patients are often based on expert opinion, with […]